Cell Source, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cell Source, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Cell Source, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $11.8M, a 14.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $11.8M +$1.48M +14.4% Dec 31, 2023 10-K 2024-06-24
Q4 2022 $10.3M +$755K +7.93% Dec 31, 2022 10-K 2024-06-24
Q4 2021 $9.52M +$1.77M +22.9% Dec 31, 2021 10-K 2023-08-08
Q4 2020 $7.74M +$13.9M Dec 31, 2020 10-K 2022-04-15
Q4 2019 -$6.2M -$1.42M -29.6% Dec 31, 2019 10-K 2021-04-15
Q4 2018 -$4.79M -$8.86M -218% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $4.07M +$408K +11.1% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $3.66M +$1.19M +47.9% Dec 31, 2016 10-K 2018-07-25
Q4 2015 $2.48M +$646K +35.3% Dec 31, 2015 10-K 2018-07-25
Q4 2014 $1.83M +$1.15M +170% Dec 31, 2014 10-K 2016-04-14
Q4 2013 $679K Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.